Embedded Files
What is Deprescribing?
What is Deprescribing?
Deprescribing means lowering the dose or stopping a medicine that may no longer be helping or may be causing harm. Deprescribing is an important part of medication management and is usually provided by a pharmacist working directly with the patient and with other members of the patient's healthcare team.
Patient Perspectives
Patient Perspectives
Our research team interviewed people on hemodialysis and clinicians at University Health Network, Toronto General Hospital to create a video. The video highlights the experiences of people on hemodialysis with medication management, including deprescribing. The video also includes patient-centred aspects of medication management, including clear and ongoing communications between patients and healthcare providers.
Watch the video and let us know what you think!
Deprescribing Tools for Patients on Hemodialysis
Patient Deprescribing Tools
Patient Deprescribing Tools
In collaboration with patients, our research team created videos and printable handouts that explain how deprescribing works, and the benefits or risks of deprescribing certain medications.
Watch the video or download the pamphlet for more information!
Ask your healthcare team which deprescribing tools are right for you. Always talk to your doctor or pharmacist before changing or stopping your medications.
How do I use the tools? What's inside?
How do I use the tools? What's inside?
Deprescribing information specific to your medication is available below in printable (PDF) or video formats (YouTube) and is free to view. For each medication, you will learn:
1. What is the medication? Why should I stop or reduce the medication?
2. How will I safely reduce or stop my medication?
3. What symptoms should my healthcare team and I watch for?
4. What should I do if my symptoms continue?
Alpha-1 Blockers
Alpha-1 Blockers
Common Names: Alfuzosin (Xatral®); Doxazosin (Cardura-1®); Prazosin (Minipress®); Silodosin (Rapaflo®); Tamsulosin (Flomax CR®); Terazosin (Hytrin®)
Benzodiazepines/Z-drugs
Benzodiazepines/Z-drugs
Common Names: Alprazolam (Xanax®); Bromazepam (Lectopam®); Chlordiazepoxide (Librium®); Clobazam (Frisium®); Clonazepam (Rivotril®); Clorazepate (Tranxene®); Diazepam (Valium®); Flurazepam; Lorazepam (Ativan®); Midazolam (Versed®); Nitrazepam; Oxazepam (Serax®); Temazepam (Restoril®); Triazolam (Halcion®)
Gabapentinoids
Gabapentinoids
Common Names: Gabapentin (Neurontin® or Auro-Gabapentin®); Pregabalin (Lyrica®)
Loop Diuretics
Loop Diuretics
Common Names: Bumetanide (Burinex®); Ethacrynic acid (Edecrin®); Furosemide (Lasix®)
Prokinetic Agents
Prokinetic Agents
Common Names: Domperidone (Motilium®); Linaclotide (Constella®); Metoclopramide (Metonia®, Reglan®); Prucalopride (Resotran®)
Proton Pump Inhibitors
Proton Pump Inhibitors
Common Names: Dexlansoprazole (Dexilant®); Esomeprazole (Nexium®); Lansoprazole (Prevacid®); Omeprazole (Losec®, Olex®); Pantoprazole magnesium (Tecta®); Pantoprazole sodium (Pantoloc®); Rabeprazole (Pariet®)
Statins
Statins
Common Names: Atorvastatin (Lipitor®); Fluvastatin (Lescol®); Lovastatin (Mevacor®); Pravastatin (Pravachol®); Rosuvastatin (Crestor®); Simvastatin (Zocor®)
STOPMed-HD Implementation Findings
March 2025
Description: A 1-page summary of results from a 6-month deprescribing intervention with patients on hemodialysis in the outpatient hemodialysis unit at Toronto General Hospital, University Health Network.
March 2025
Description: A 1-page summary of results from interviews with patients on hemodialysis and clinicians who participated in a 6-month deprescribing intervention at Toronto General Hospital, University Health Network.
Please contact your doctor or pharmacist before changing or stopping any medications.
Page updated
Google Sites
Report abuse